Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:Medindia updates the prices regularly, however, ...
TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize ...
If and when approved, the product will enter the topical fungicides market that is estimated to be C$88 million on an annual basis* Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 8, ...
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” PINK SHEETS: TAROF) reported today that it has received final approval from the U.S. Food and Drug Administration (“FDA”) ...
The FDA today approved the first generic versions of Novartis’ Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). The agency approved applications from ...
July 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for paroxetine hydrochloride extended release tablets, 12.5 mg and 25 mg, for the treatment of ...
Lamisil Tablets contain the synthetic allylamine antifungal compound terbinafine hydrochloride. Terbinafine hydrochloride is a white to off-white fine crystalline powder. It is freely soluble in ...
The labeling for Lamisil (terbinafine hydrochloride) Tablets and Oral Granules has been updated to include a new warning regarding the risk of thrombotic microangiopathy. The labeling for Lamisil ...
There are different types of fungal infections, and different types of treatments for these infections. Some of these treatments are not recommended for people with lupus. If you have lupus, it is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback